Ovary Cancer

Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological Malignancies

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines

Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health

INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study

An Exploratory Study on the Use of Ipalotinib (Tislelizumab) Combined With Sunitinib and Olaparib for Neoadjuvant Therapy in HRD-positive Advanced Ovarian Cancer

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy

GYNecologic Cancer-Related COGnitive Impairment

Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Multimedia Aid for Genetic Testing in Gynecologic Oncology

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

No-Stoma Policy in Advanced Ovarian Cancer Surgery

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK

A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer